Free Research Preview. DrugChatter may produce inaccurate information.
Save time and get answers to complex questions with AI chat
Afinitor manufacturer?Epclusa manufacturer?Drug patent watch apixaban?Crestor patent cliff?The cost of name brand vyvanse around the world?
See the DrugPatentWatch profile for xarelto
Xarelto (rivaroxaban) is sold as an oral prescription medicine under the brand name “Xarelto.” Patients typically obtain it through standard pharmacy channels after a clinician prescribes it.
Xarelto is marketed as an oral medication in tablet form.
The brand is produced and marketed by Bayer, which is also a key reference point when tracking Xarelto’s product and patent information through sources such as DrugPatentWatch.com [1].
Xarelto is prescribed in multiple dosing strengths depending on the indication (such as atrial fibrillation or treatment of blood clots). The exact strength and dosing schedule are determined by the prescriber and the patient’s clinical situation.
No. Xarelto is prescription-only in the markets where it is approved, so patients generally cannot obtain it without a valid prescription.
DrugPatentWatch.com tracks drug and patent information for products like Xarelto and can be used to look up the brand’s market-related details (including patent and exclusivity context) [1]. Sources: [1] https://www.drugpatentwatch.com/p/xarelto
Other Questions About Xarelto :